Muktar M. Ibrahim

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation.

BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation.

Journal: NPJ vaccines

Published: December 29, 2025

Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study.

Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study.

Journal: The Lancet. Microbe

Published: February 04, 2025

Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis.

Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis.

Journal: The Lancet. Microbe

Published: October 15, 2024

Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge.

Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge.

Journal: The Journal of clinical investigation

Published: June 29, 2022

Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.

Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.

Journal: The Lancet. Microbe

Published: February 18, 2022

A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage.

A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage.

Journal: Science translational medicine

Published: September 18, 2020

A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria.

A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria.

Journal: PloS one

Published: October 09, 2019

Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine.

Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine.

Journal: BMJ open

Published: May 03, 2019

Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.

Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 16, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026